Dr. Reddy's Laboratories Ltd. announcements
In the twelve months since 23 September 2025 Dr. Reddy's Laboratories Ltd. made 144 announcements to NSE under Regulation 30: 31 general updates, 22 analysts/institutional investor meet/con. call updates, 18 copy of newspaper publication, 15 press release, 9 updates, 8 news verification. The latest, on 22 September 2026, was filed under trading window; the table carries the company's own summary of each and the PDF.
| Date | Category | What the company told the exchange | Filing |
|---|---|---|---|
| 22 September 2026 | Trading Window | Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 21 September 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 18 September 2026 | Arrangements for strategic, technical, manufacturing, or marketing tie up | Dr. Reddy's Laboratories Limited has today, i.e., September 18, 2026, entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India Private Limited for Qdenga® in the private market in India. | |
| 18 September 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets voluntary licence for Gilead s once-yearly HIV prevention drug. The response from the Company is attached. | |
| 17 September 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets voluntary licence for Gilead s once-yearly HIV prevention drug. The response from the Company is awaited. | |
| 16 September 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 11 September 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 10 September 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock options | |
| 10 September 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 26 August 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of employee stock options | |
| 20 August 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 14 August 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 14 August 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 13 August 2026 | Resignation of Director/KMP/SMP | Dr. Reddy's Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP | |
| 13 August 2026 | Change in Management | Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management | |
| 7 August 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 1 August 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015". | |
| 29 July 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 29 July 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddys antibiotic gets Thailand approval six months after US nod. The response from the Company is attached. | |
| 28 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript | |
| 28 July 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddys antibiotic gets Thailand approval six months after US nod. The response from the Company is awaited. | |
| 23 July 2026 | Change in Auditors | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Auditors of the company. | |
| 23 July 2026 | Change in Director(s) | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. | |
| 23 July 2026 | Shareholders meeting | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 23, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | |
| 23 July 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 23 July 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 23, 2026, titled "Intimation of Earnings call recording". | |
| 22 July 2026 | Investor Presentation | Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation | |
| 22 July 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about allotment of Employee Stock Options | |
| 22 July 2026 | Change in Management | Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management | |
| 22 July 2026 | Outcome of Board Meeting | Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | |
| 15 July 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Conference call Transcript | |
| 13 July 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 13, 2026, titled "Intimation of Earnings call". | |
| 10 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording | |
| 9 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Conference Call | |
| 9 July 2026 | General Updates | Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | |
| 3 July 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 1 July 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 30 June 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Letter to shareholders in relation to Integrated Annual Report of the Company for FY 2025-26'. | |
| 30 June 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Integrated Annual Report FY 2026 | |
| 30 June 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report FY 2026'. | |
| 30 June 2026 | Shareholders meeting | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on July 23, 2026 | |
| 25 June 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 22 June 2026 | Trading Window | Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 20 June 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper advertisement titled Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information | |
| 19 June 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee stock options'. | |
| 13 June 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 13, 2026, titled "Dr. Reddy s announces the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States.". | |
| 12 June 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 12 June 2026 | Disclosure under SEBI Takeover Regulations | Kallam Satish Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | |
| 10 June 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 5 June 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock Options | |
| 3 June 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analyst/Investor meet | |
| 1 June 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about | |
| 30 May 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange that the Annual Report in Form 20F for the fiscal year ended March 31, 2026 has been filed with United States Securities and Exchange Commission. | |
| 28 May 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Dr. Reddy's Laboratories to Ring the Closing Bell® at the New York Stock Exchange. | |
| 27 May 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 18 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript | |
| 16 May 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada". | |
| 13 May 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 12 May 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2026, titled "Recordings of Earnings call". | |
| 12 May 2026 | Investor Presentation | Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation | |
| 12 May 2026 | Change in Management | Dr. Reddy's Laboratories Limited has informed the Exchange about elevation of Mr. Sandeep Khandelwal as a Senior Management Personnel. | |
| 12 May 2026 | Change in Director(s) | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. | |
| 12 May 2026 | Change in Auditors | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Auditors of the company. | |
| 12 May 2026 | Record Date | Dr. Reddy's Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 10-Jul-2026. | |
| 12 May 2026 | Dividend | Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 12, 2026, recommended Final Dividend of Rs. 8 per equity share. | |
| 12 May 2026 | Outcome of Board Meeting | Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | |
| 11 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 11 May 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Grant of Employee Stock Options | |
| 29 April 2026 | Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals | Dr. Reddy's Laboratories Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals | |
| 24 April 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 24, 2026, titled "Intimation of Earnings call". | |
| 24 April 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 24 April 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddys Laboratories still awaiting approval for a major near-term trigger, sources say. The response from the Company is attached. | |
| 24 April 2026 | Rumour Verification - Regulation 30(11) | Dr. Reddy's Laboratories Limited has informed the Exchange about Rumour Verification - Regulation 30(11) | |
| 23 April 2026 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddys Laboratories still awaiting approval for a major near-term trigger, sources say. The response from the Company is awaited. | |
| 16 April 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Board meeting intimation for recommending final dividend, if any, for Financial Year 2025-26 | |
| 14 April 2026 | Action(s) taken or orders passed | Dr. Reddy's Laboratories Limited has informed the Exchange about Dr. Reddy s Laboratories LLC, Russia, a step-down wholly-owned subsidiary has received a final penalty decision from the Tax Authority. | |
| 8 April 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 7 April 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about sale of wholly owned subsidiary | |
| 26 March 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'. | |
| 24 March 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Revised Code of Practices and Procedures for Fair Disclosures of Un-published Price Sensitive Information.' | |
| 23 March 2026 | Trading Window | Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 21 March 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Dr. Reddy s Laboratories announces launch of India s first DCGI-approved Semaglutide injection Obeda® for Type 2 Diabetes.". | |
| 17 March 2026 | Action(s) taken or orders passed | Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passed | |
| 13 March 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 12 March 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 12 March 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock Options | |
| 10 March 2026 | Rumour Verification - Regulation 30(11) | Dr. Reddy's Laboratories Limited has informed the Exchange about Rumour Verification - Regulation 30(11) | |
| 10 March 2026 | Change in Management | Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management | |
| 6 March 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 5 March 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 27 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 24 February 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 18 February 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India". | |
| 17 February 2026 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'. | |
| 12 February 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 12 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 9 February 2026 | Resignation | Dr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Sushrut Kulkarni as Other of the company w.e.f. May 08, 2026. | |
| 2 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 27 January 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript | |
| 24 January 2026 | Action(s) initiated or orders passed | Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed | |
| 22 January 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 21 January 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording | |
| 21 January 2026 | Investor Presentation | Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation | |
| 21 January 2026 | Outcome of Board Meeting | Dr. Reddy's Laboratories Limited has submitted to the Exchange, unaudited financial results for the quarter and nine months ended December 31, 2025. | |
| 14 January 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Dr. Reddy s announces the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.". | |
| 10 January 2026 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 | |
| 8 January 2026 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "Intimation of Earnings call". | |
| 6 January 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 6 January 2026 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 1 January 2026 | Action(s) taken or orders passed | Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passed | |
| 31 December 2025 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'. | |
| 23 December 2025 | Trading Window | Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| 17 December 2025 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 16 December 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 12 December 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 12 December 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 12 December 2025 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 12, 2025, titled "Dr. Reddy s Laboratories announces Science-Based Net Zero Climate Targets". | |
| 9 December 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 8 December 2025 | Arrangements for strategic, technical, manufacturing, or marketing tie up | Dr. Reddy's Laboratories Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up | |
| 2 December 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 28 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 26 November 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 26 November 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 24 November 2025 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 24, 2025, titled "Dr. Reddy s receives European Commission approval for AVT03 (denosumab), a proposed Biosimilar of Prolia® and Xgeva®". | |
| 18 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 18 November 2025 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 17 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet | |
| 14 November 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 13 November 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of 7,430 Equity Shares on exercise of Stock Options under ESOPs | |
| 11 November 2025 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Hackers dupe Dr Reddy's Laboratories of ₹2.16 crore here's how the cyber fraud unfolded. The response from the Company is attached. | |
| 10 November 2025 | News Verification | The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Hackers dupe Dr Reddy's Laboratories of ₹2.16 crore here's how the cyber fraud unfolded. The response from the Company is awaited. | |
| 10 November 2025 | Change in Management | Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management | |
| 5 November 2025 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 30 October 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript | |
| 29 October 2025 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'. | |
| 25 October 2025 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 25 October 2025 | Updates | Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Earnings call recordings'. | |
| 24 October 2025 | General Updates | Update on Senior Management Personnel | |
| 24 October 2025 | Investor Presentation | Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation | |
| 24 October 2025 | Outcome of Board Meeting | Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | |
| 21 October 2025 | General Updates | Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates | |
| 13 October 2025 | Press Release | Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 13, 2025, titled "Initmation of Earnings call". | |
| 7 October 2025 | Copy of Newspaper Publication | Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | |
| 1 October 2025 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Regulation 30 of SEBI's listing regulations requires a company to tell the exchange of material events; the category is the exchange's, the words are the company's own summary as filed, cut to a few lines, and the PDF is the full filing.
Source
Corporate announcements on nseindia.com for DRREDDY.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.